Mitchell Arnold

Vice President of Finance (Principal Financial and Accounting Officer), Petros Pharmaceuticals, Inc.

Former. First published here October 28, 2026; built from records as of October 28, 2026.

Petros Pharmaceuticals, Inc. named Robert Weinstein to succeed Mitchell Arnold, effective June 18, 2026.²

Seats

The seat in the record

Company	Title as filed	Standing	Filings
Petros Pharmaceuticals, Inc. (PTPI) Pharmaceutical Preparations	Vice President of Finance (Principal Financial and Accounting Officer)	Former	2

Company names link to the company's page in the record at CFO Tribune, which holds the seat history.

The record

Filing by filing, latest first

June 18, 2026effective
Petros Pharmaceuticals, Inc. named Robert Weinstein to succeed Mitchell Arnold, effective June 18, 2026. Profile of Robert Weinstein.
[2] Filing by Petros Pharmaceuticals, Inc., filed with the SEC on June 18, 2026. Read the filing. The record at CFO Tribune.
April 15, 202610-K filed
Mitchell Arnold signed the annual report of Petros Pharmaceuticals, Inc. on Form 10-K as Vice President of Finance (Principal Financial and Accounting Officer), filed April 15, 2026.
/s/ Mitchell Arnold Vice President of Finance April 15, 2026 Mitchell Arnold (Principal Financial and Accounting Officer)
[1] Annual report on Form 10-K by Petros Pharmaceuticals, Inc., filed with the SEC on April 15, 2026. Read the filing. The record at CFO Tribune.

Sources

Annual report on Form 10-K, Petros Pharmaceuticals, Inc.. U.S. Securities and Exchange Commission, EDGAR, filed April 15, 2026. sec.gov; record.
Current report filed with the SEC, Petros Pharmaceuticals, Inc.. U.S. Securities and Exchange Commission, EDGAR, filed June 18, 2026. sec.gov; record.

Corrections and removal

If a line here is wrong, or Mitchell Arnold wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.